Literature DB >> 17146576

Optical aberrations and visual disturbances associated with dry eye.

Eiki Goto1, Reko Ishida, Minako Kaido, Murat Dogru, Yukihiro Matsumoto, Takashi Kojima, Kazuo Tsubota.   

Abstract

Optical aberrations and visual disturbances are associated with dry eye, although visual impairment is often not detected by conventional visual acuity testing. The newly developed functional visual acuity (FVA) device allows continuous dynamic evaluation of distance visual acuity and assessment of the effect of natural tear film status on dynamic visual function. Similarly, to detect corneal surface irregularities during sustained eye opening in dry eye subjects, a new tear stability analysis system (TSAS) has been developed. Both FVA and TSAS measurement systems seem to be effective tools in the assessment of dynamic visual acuity changes in dry eye and normal subjects. Both methods were also found to be helpful in the evaluation of the outcome of management of dry eye disease. FVA testing has been suggested to be an important indication of an individual's performance in relation to certain daily activities, such as driving, reading and working at a video display terminal. This review provides illustrations of results obtained from FVA and TSAS systems.

Entities:  

Mesh:

Year:  2006        PMID: 17146576     DOI: 10.1016/s1542-0124(12)70167-2

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  11 in total

1.  Measurement of the time course of optical quality and visual deterioration during tear break-up.

Authors:  Haixia Liu; Larry Thibos; Carolyn G Begley; Arthur Bradley
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

2.  Decrease of tear break-up time at Japanese eye clinics during five consecutive years.

Authors:  Masahiko Ayaki; Kazuno Negishi
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

3.  Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.

Authors:  Amalia Enríquez-de-Salamanca; Evangelina Castellanos; Michael E Stern; Itziar Fernández; Ester Carreño; Carmen García-Vázquez; Jose M Herreras; Margarita Calonge
Journal:  Mol Vis       Date:  2010-05-19       Impact factor: 2.367

4.  Dry Eye Disease: Impact on Quality of Life and Vision.

Authors:  Miki Uchino; Debra A Schaumberg
Journal:  Curr Ophthalmol Rep       Date:  2013-06

5.  Non-invasive assessment of tear film stability with a novel corneal topographer in Indian subjects.

Authors:  Vipul Bhandari; Jagdeesh K Reddy; Kirti Relekar; Ameya Ingawale; Neeraj Shah
Journal:  Int Ophthalmol       Date:  2016-02-18       Impact factor: 2.031

6.  The impact of tear functions on visual outcome following keratoplasty in eyes with keratoconus.

Authors:  Shuya Hara; Takashi Kojima; Murat Dogru; Yuichi Uchino; Eiki Goto; Yukihiro Matsumoto; Tetsuya Kawakita; Kazuo Tsubota; Jun Shimazaki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-22       Impact factor: 3.117

7.  Diagnostic tests in dry eye.

Authors:  Amy Kloosterboer; Harrison Isaac Dermer; Anat Galor
Journal:  Expert Rev Ophthalmol       Date:  2019-08-29

8.  The challenge of dry eye diagnosis.

Authors:  Giacomo Savini; Pinita Prabhawasat; Takashi Kojima; Martin Grueterich; Edgar Espana; Eiki Goto
Journal:  Clin Ophthalmol       Date:  2008-03

9.  Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline.

Authors:  Sakiko Minami; Norihiro Nagai; Misa Suzuki; Toshihide Kurihara; Hideki Sonobe; Mamoru Kamoshita; Atsuro Uchida; Hajime Shinoda; Hitoshi Takagi; Shozo Sonoda; Taiji Sakamoto; Kazuo Tsubota; Yoko Ozawa
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

10.  Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.

Authors:  Ranjan Malhotra; Douglas K Devries; Jodi Luchs; Alan Kabat; Barry A Schechter; Bridgitte Shen Lee; Lee Shettle; Robert Smyth-Medina; Abayomi Ogundele; Charles Darby; Jason Bacharach; Paul Karpecki
Journal:  Cornea       Date:  2019-10       Impact factor: 2.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.